Form 8-K BRIDGE BANCORP INC For: Jan 07
�
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
�
�
FORM�8-K
�
�
CURRENT REPORT
�
PURSUANT TO SECTION�13 OR 15(d)�OF THE
SECURITIES EXCHANGE ACT OF 1934
�
�
Date of report (Date of earliest event reported):��January�7, 2015
�
�
�
BRIDGE BANCORP,�INC.
(Exact name of the registrant as specified in its charter)
�
�
New York |
� |
001-34096 |
� |
11-2934195 | ||
(State or other jurisdiction of |
� |
(Commission File Number) |
� |
(IRS Employer | ||
� | ||||||
2200 Montauk Highway |
� |
� |
� |
� | ||
Bridgehampton, New York |
� |
� |
� |
11932 | ||
(Address of principal executive offices) |
� |
� |
� |
(Zip Code) | ||
�
�
(631) 537-1000
(Registrant�s telephone number)
�
N/A
(Former name or former address, if changed since last report)
�
�
�
Check the appropriate box below if the Form�8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):
�
o |
Written communications pursuant to Rule�425 under the Securities Act (17 CFR 230.425) |
o |
Soliciting material pursuant to Rule�14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o |
Pre-commencement communications pursuant to Rule�14d-2(b)�under the Exchange Act (17 CFR 240.14d-2(b)) |
o |
Pre-commencement communications pursuant to Rule�13e-4(c)�under the Exchange Act (17 CFR 240.13e-4c) |
�
�
�
Item 8.01������������������������������������������ Other Events.
�
On January�7, 2015 the Registrant announced the declaration of a quarterly cash dividend of $0.23 per share, payable on January�30, 2015 to shareholders of record as of January�20, 2015.��A copy of the press release announcing the dividend is attached as Exhibit 99.1 to this Current Report.
�
�
Item 9.01������������������������������������������� Financial Statements and Exhibits.
�
(a)��Not Applicable.
�
(b)��Not Applicable.
�
(c)��Not Applicable.
�
(d)��Exhibits.
�
Exhibit No. |
Exhibit |
Press Release dated� January�7, 2015 |
�
�
�
�
SIGNATURE
�
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
�
�
Bridge Bancorp,�Inc.
(Registrant)
�
�
�
By: /s/ Howard H. Nolan
Howard H. Nolan
Sr. Executive Vice President and Chief Financial Officer
�
�
�
Dated:��January�7, 2015
�
�
Press Release
FOR IMMEDIATE RELEASE
�
�
�
Contact: |
Howard H. Nolan |
|
� |
Senior Executive Vice President | |
� |
Chief Financial Officer and Corporate Secretary | |
� |
(631) 537-1000, ext. 7255 |
�����������������������
�
BRIDGE BANCORP,�INC. ANNOUNCES FOURTH QUARTER 2014 DIVIDEND
�
(Bridgehampton, NY �January�7, 2015)� Bridge Bancorp,�Inc. (NASDAQ�: BDGE), the holding company for The Bridgehampton National Bank, announced the declaration of a quarterly dividend of $0.23 per share.� The dividend will be payable on January�30, 2015 to shareholders of record as of January�20, 2015.� The Company continues its trend of uninterrupted dividends.
�
Bridge Bancorp,�Inc. is a bank holding company engaged in commercial banking and financial services through its wholly owned subsidiary, The Bridgehampton National Bank (BNB).� Established in 1910, BNB, with assets of approximately $2.2 billion, and a primary market area of Suffolk and Southern Nassau Counties, Long Island, operates 29 retail branch locations. Through this branch network and its electronic delivery channels, BNB provides deposit and loan products and financial services to local businesses, consumers and municipalities. Title insurance services are offered through BNB�s wholly owned subsidiary, Bridge Abstract.� Bridge Financial Services LLC offers financial planning and investment consultation.
�
BNB also has a rich tradition of involvement in the community, supporting programs and initiatives that promote local business, the environment, education, healthcare, social services and the arts.
�
####
�
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice
- Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
- Notice of 2024 First Quarter Results Conference Call and Webcast for Investors and Analysts and Annual Meeting of Shareholders
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!